Catalyst Wire Dossier Catalyst Wire Dossier

PegIntron Pen

pegylated interferon alfa-2b · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PegIntron Pen, covering 2009-06-02 to 2013-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

See pricing